{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T06:31:45Z","timestamp":1795156305953,"version":"4.10.3"},"reference-count":222,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T00:00:00Z","timestamp":1697155200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003693","name":"Korea Institute of Science and Technology","doi-asserted-by":"publisher","award":["2E32333"],"award-info":[{"award-number":["2E32333"]}],"id":[{"id":"10.13039\/501100003693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003693","name":"Korea Institute of Science and Technology","doi-asserted-by":"publisher","award":["2ME1650"],"award-info":[{"award-number":["2ME1650"]}],"id":[{"id":"10.13039\/501100003693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["CAP23011\\u2013100"],"award-info":[{"award-number":["CAP23011\\u2013100"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009367","name":"Mansoura University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004080","name":"Korea Drug Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004080","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008783","name":"National Research Council of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008783","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.biopha.2023.115734","type":"journal-article","created":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T05:52:27Z","timestamp":1697521947000},"page":"115734","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":641,"special_numbering":"C","title":["Diabetes mellitus: Classification, mediators, and complications; A gate to identify potential targets for the development of new effective treatments"],"prefix":"10.1016","volume":"168","author":[{"given":"Samar A.","family":"Antar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada A.","family":"Ashour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa","family":"Sharaky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Khattab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naira A.","family":"Ashour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roaa T.","family":"Zaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Joo","family":"Roh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Elkamhawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed A.","family":"Al-Karmalawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.biopha.2023.115734_bib1","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.3390\/ijms21051835","article-title":"The diabetes mellitus\u2013atherosclerosis connection: The role of lipid and glucose metabolism and chronic inflammation","volume":"21","author":"Poznyak","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2023.115734_bib2","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.numecd.2019.04.009","article-title":"Impact of severe and symptomatic hypoglycemia on quality of life and fear of hypoglycemia in type 1 and type 2 diabetes. Results of the Hypos-1 observational study","volume":"29","author":"Rossi","year":"2019","journal-title":"Nutr., Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.biopha.2023.115734_bib3","unstructured":"WHO, Diabetes, 2019."},{"issue":"Supplement_1","key":"10.1016\/j.biopha.2023.115734_bib4","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.2337\/dc23-S002","article-title":"2. Classification and diagnosis of diabetes: standards of care in diabetes\u20142023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes care"},{"issue":"1","key":"10.1016\/j.biopha.2023.115734_bib5","first-page":"37","article-title":"Type 1 diabetes\u2013a clinical perspective","volume":"16","author":"Kahanovitz","year":"2017"},{"issue":"2","key":"10.1016\/j.biopha.2023.115734_bib6","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/dme.12048","article-title":"The broad clinical phenotype of Type 1 diabetes at presentation","volume":"30","author":"Merger","year":"2013","journal-title":"Diabetic Medicine"},{"issue":"5","key":"10.1016\/j.biopha.2023.115734_bib7","first-page":"577","article-title":"Fulminant type 1 diabetes mellitus","volume":"53","author":"Imagawa","year":"2006"},{"issue":"8","key":"10.1016\/j.biopha.2023.115734_bib8","first-page":"959","article-title":"Fulminant type 1 diabetes\u2014an important subtype in East Asia","volume":"27","author":"Imagawa","year":"2011","journal-title":"reviews"},{"issue":"17","key":"10.1016\/j.biopha.2023.115734_bib9","first-page":"6275","article-title":"Pathophysiology of type 2 diabetes mellitus","volume":"21","author":"Galicia-Garcia","year":"2020"},{"issue":"3","key":"10.1016\/j.biopha.2023.115734_bib10","first-page":"827","article-title":"Alterations in pancreatic \u03b2 cell function and Trypanosoma cruzi infection: evidence from human and animal studies","volume":"116","author":"Dufurrena","year":"2017"},{"issue":"8","key":"10.1016\/j.biopha.2023.115734_bib11","first-page":"676","article-title":"Beta-cell failure in type 2 diabetes: mechanisms, markers, and clinical implications","volume":"132","author":"Wysham","year":"2020"},{"issue":"10","key":"10.1016\/j.biopha.2023.115734_bib12","first-page":"1880","article-title":"High maternal early-pregnancy blood glucose levels are associated with altered fetal growth and increased risk of adverse birth outcomes","volume":"62","author":"Geurtsen","year":"2019"},{"issue":"2","key":"10.1016\/j.biopha.2023.115734_bib13","first-page":"125","article-title":"Gestational diabetes: a review of the current literature and guidelines","volume":"62","author":"Hollander","year":"2007","journal-title":"G. Surv."},{"issue":"11","key":"10.1016\/j.biopha.2023.115734_bib14","first-page":"3342","article-title":"The pathophysiology of gestational diabetes mellitus","volume":"19","author":"Plows","year":"2018"},{"key":"10.1016\/j.biopha.2023.115734_bib15","doi-asserted-by":"crossref","unstructured":"C.F. Chukwunyere, D.O. Awonuga, O.F. Adesina, I.C.J.D. Udenze, Gestational diabetes: Comparison of random and fasting plasma glucose as modalities of screening, 2020. https:\/\/www.emjreviews.com\/wp-content\/uploads\/2020\/11\/Gestational-Diabetes-Comparison-of-Random-and-Fasting-Plasma-Glucose-as-Modalities-of-Screening.pdf.","DOI":"10.33590\/emjdiabet\/20-00119"},{"issue":"6","key":"10.1016\/j.biopha.2023.115734_bib16","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1136\/adc.2005.088229","article-title":"\u03b2-cell autoantibodies in children with type 2 diabetes mellitus: subgroup or misclassification?","volume":"91","author":"Reinehr","year":"2006","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.biopha.2023.115734_bib17","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1007\/s00125-016-4087-0","article-title":"Beta cell function and ongoing autoimmunity in long-standing, childhood onset type 1 diabetes","volume":"59","author":"Williams","year":"2016","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.biopha.2023.115734_bib18","doi-asserted-by":"crossref","first-page":"645","DOI":"10.2337\/diabetes.53.3.645","article-title":"Ketosis-prone type 2 diabetes in patients of sub-Saharan African origin: clinical pathophysiology and natural history of \u03b2-cell dysfunction and insulin resistance","volume":"53","author":"Mauvais-Jarvis","year":"2004","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.biopha.2023.115734_bib19","first-page":"1","article-title":"Update on diabetes classification","volume":"99","author":"Thomas","year":"2015","journal-title":"Med. Clin."},{"key":"#cr-split#-10.1016\/j.biopha.2023.115734_bib20.1","unstructured":"A.D. Association, Diagnosis and classification of diabetes mellitus. Diabetes Care 2010"},{"key":"#cr-split#-10.1016\/j.biopha.2023.115734_bib20.2","doi-asserted-by":"crossref","unstructured":"33 (Suppl. 1): S62-S69, Erratum in: Diabetes Care 33, 2010: e57. https:\/\/doi.org\/10.2337\/dc10-S062.","DOI":"10.2337\/dc10-S062"},{"issue":"1","key":"10.1016\/j.biopha.2023.115734_bib21","first-page":"1","article-title":"Classification of diabetes mellitus","volume":"21","author":"Kazi","year":"2001","journal-title":"Clin. Lab. Med."},{"issue":"6","key":"10.1016\/j.biopha.2023.115734_bib22","first-page":"371","article-title":"The prevalence of insulin receptor antibodies in patients with systemic lupus erythematosus and related conditions","volume":"7","author":"Rosenstein","year":"2001","journal-title":"JCR: J. Clin. Rheumatol."},{"issue":"10","key":"10.1016\/j.biopha.2023.115734_bib23","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.2337\/dbi20-0001","article-title":"Subtypes of Type 2 Diabetes Determined From Clinical Parameters","volume":"69","author":"Ahlqvist","year":"2020","journal-title":"Diabetes"},{"issue":"24","key":"10.1016\/j.biopha.2023.115734_bib24","doi-asserted-by":"crossref","first-page":"9523","DOI":"10.3390\/ijerph17249523","article-title":"The identification of diabetes mellitus subtypes applying cluster analysis techniques: a systematic review","volume":"17","author":"Sarr\u00eda-Santamera","year":"2020","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"3","key":"10.1016\/j.biopha.2023.115734_bib25","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1007\/s10462-022-10202-8","article-title":"Diabetes subtypes classification for personalized health care: A review","volume":"56","author":"Omar","year":"2023","journal-title":"Artif. Intell. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2023.115734_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-34754-z","article-title":"Metabolic and proteomic signatures of type 2 diabetes subtypes in an Arab population","volume":"13","author":"Zaghlool","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2023.115734_bib27","article-title":"Aetiological differences between novel subtypes of diabetes derived from genetic associations","author":"Aly","year":"2020","journal-title":"medRxiv"},{"issue":"2","key":"10.1016\/j.biopha.2023.115734_bib28","first-page":"251","article-title":"globin A1c alone an efficient screening test for undiagnosed diabetes?","volume":"76","author":"Nakagami","year":"2007","journal-title":"Jpn. Is. Meas. glycated hemoNational Diabetes Surv."},{"issue":"11","key":"10.1016\/j.biopha.2023.115734_bib29","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.2337\/diacare.26.11.3160","article-title":"Follow-up report on the diagnosis of diabetes mellitus","volume":"26","author":"Genuth","year":"2003","journal-title":"Diabetes care"},{"issue":"6","key":"10.1016\/j.biopha.2023.115734_bib30","first-page":"850","article-title":"Diabetes mellitus: The epidemic of the century","volume":"6","author":"Kharroubi","year":"2015","journal-title":"H. M. J. W. J. o. D. Darwish"},{"key":"10.1016\/j.biopha.2023.115734_bib31","doi-asserted-by":"crossref","unstructured":"American Diabetes Association, 2021. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes\u20142021. Diabetes care, 44(Supplement_1), pp.S15-S33.","DOI":"10.2337\/dc21-S002"},{"key":"10.1016\/j.biopha.2023.115734_bib32","doi-asserted-by":"crossref","unstructured":"N. Xu, H. Wu, D. Li, J.J.Dr Wang, c practice, Diagnostic accuracy of glycated hemoglobin compared with oral glucose tolerance test for diagnosing diabetes mellitus in Chinese adults: a meta-analysis, 106(1), 2014: 11\u201318. https:\/\/doi.org\/10.1016\/j.diabres.2014.04.010.","DOI":"10.1016\/j.diabres.2014.04.010"},{"key":"10.1016\/j.biopha.2023.115734_bib33","doi-asserted-by":"crossref","unstructured":"S. Sivaprasad, B. Gupta, M.C. Gulliford, H. Dodhia, M. Mohamed, D. Nagi, J.R.J.Po Evans, Ethnic variations in the prevalence of diabetic retinopathy in people with diabetes attending screening in the United Kingdom (DRIVE UK), 7(3), 2012: e32182. https:\/\/doi.org\/10.1371\/journal.pone.0032182.","DOI":"10.1371\/journal.pone.0032182"},{"key":"10.1016\/j.biopha.2023.115734_bib34","doi-asserted-by":"crossref","unstructured":"T. Grant, Y. Soriano, P.R. Marantz, I. Nelson, E. Williams, D. Ramirez, J. Burg, C.J.Ajopm Nordin, Community-based screening for cardiovascular disease and diabetes using HbA1c, 26(4), 2004: 271\u2013275. https:\/\/doi.org\/10.1016\/j.amepre.2003.12.015.","DOI":"10.1016\/j.amepre.2003.12.015"},{"key":"10.1016\/j.biopha.2023.115734_bib35","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cotox.2017.09.003","article-title":"Environmental toxicant exposures and type 2 diabetes mellitus: two interrelated public health problems on the rise","volume":"7","author":"Bonini","year":"2018","journal-title":"Curr. Opin. Toxicol."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2023.115734_bib36","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cca.2006.07.005","article-title":"Molecular mechanisms of insulin resistance and associated diseases","volume":"375","author":"Mlinar","year":"2007","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.biopha.2023.115734_bib37","first-page":"8","article-title":"The gut microbiome and type 2 diabetes mellitus: discussing a complex relationship","volume":"8","author":"Sikalidis","year":"2020"},{"key":"10.1016\/j.biopha.2023.115734_bib38","doi-asserted-by":"crossref","DOI":"10.1007\/s10787-023-01144-w","article-title":"Bioactive fraction from Plumeria obtusa L. attenuates LPS-induced acute lung injury in mice and inflammation in RAW 264.7 macrophages: LC\/QToF-MS and molecular docking","author":"Eloutify","year":"2023","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.biopha.2023.115734_bib39","doi-asserted-by":"crossref","DOI":"10.34172\/PS.2022.4","article-title":"Protective effects of mirazid on gentamicin-induced nephrotoxicity in rats through antioxidant, anti-inflammatory, JNK1\/iNOS, and apoptotic pathways; novel mechanistic insights","author":"Antar","year":"2022","journal-title":"Pharm. Sci."},{"issue":"9911","key":"10.1016\/j.biopha.2023.115734_bib40","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0140-6736(13)60591-7","article-title":"Type 1 diabetes","volume":"383","author":"Atkinson","year":"2014","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.biopha.2023.115734_bib41","first-page":"1370","article-title":"How does type 1 diabetes develop?","volume":"60","author":"Atkinson","year":"2011","journal-title":"Notion Homicide Or. \u03b2-Cell Suicide Revisit., Diabetes"},{"issue":"7892","key":"10.1016\/j.biopha.2023.115734_bib42","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0140-6736(74)90140-8","article-title":"Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies","volume":"304","author":"Bottazzo","year":"1974","journal-title":"Lancet"},{"issue":"9277","key":"10.1016\/j.biopha.2023.115734_bib43","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0140-6736(01)05415-0","article-title":"Type 1 diabetes: new perspectives on disease pathogenesis and treatment","volume":"358","author":"Atkinson","year":"2001","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.biopha.2023.115734_bib44","doi-asserted-by":"crossref","first-page":"847","DOI":"10.2337\/diabetes.53.3.847","article-title":"Genetic polymorphisms in peroxisome proliferator-activated receptor \u03b4 associated with obesity","volume":"53","author":"Shin","year":"2004","journal-title":"Diabetes"},{"issue":"23","key":"10.1016\/j.biopha.2023.115734_bib45","first-page":"3941","article-title":"Insulitis in Human Type 1 Diabetic Pancreas: From Stem Cell Grafting to Islet Organoids for a Successful Cell-Based Therapy","volume":"11","author":"La Noce","year":"2022"},{"key":"10.1016\/j.biopha.2023.115734_bib46","series-title":"Translational Autoimmunity","first-page":"325","article-title":"Immunological tolerance and autoimmunity","author":"Valdes","year":"2022"},{"key":"10.1016\/j.biopha.2023.115734_bib47","doi-asserted-by":"crossref","first-page":"669456","DOI":"10.3389\/fimmu.2021.669456","article-title":"Glycolysis inhibition induces functional and metabolic exhaustion of CD4+ T cells in type 1 diabetes","volume":"12","author":"Martins","year":"2021","journal-title":"Frontiers in immunology"},{"issue":"4","key":"10.1016\/j.biopha.2023.115734_bib48","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.3390\/ijms24044004","article-title":"Fibrosis: Types, Effects, Markers, Mechanisms for Disease Progression, and Its Relation with Oxidative Stress, Immunity, and Inflammation","volume":"24","author":"Antar","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.115734_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121390","article-title":"Metformin ameliorates doxorubicin induced cardiotoxicity targeting HMGB1\/TLR4\/NLRP3 signaling pathway in mice","author":"Alzokaky","year":"2023","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.biopha.2023.115734_bib50","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3483","article-title":"Neutrophils and their role in the aetiopathogenesis of type 1 and type 2 diabetes","volume":"38","author":"Giovenzana","year":"2022","journal-title":"Diabetes\/Metabolism Research and Reviews"},{"issue":"2","key":"10.1016\/j.biopha.2023.115734_bib51","volume":"10","author":"Yang","year":"2021","journal-title":"Nat. Kill. Cells Inflamm. autoimmune Dis."},{"key":"10.1016\/j.biopha.2023.115734_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.121184","article-title":"Glimepiride ameliorates renal toxicity induced by cadmium in mice: Modulation of Jun N terminal kinase (JNK)\/nuclear factor kappa B (NF-\u03baB) and phosphatidylinositol 3-kinases (PI3K)\/protein kinase (AKT) pathways","author":"ElMahdy","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2023.115734_bib53","doi-asserted-by":"crossref","first-page":"104590","DOI":"10.1016\/j.cellimm.2022.104590","article-title":"The interferon regulatory factors, a double-edged sword, in the pathogenesis of type 1 diabetes","author":"Yang","year":"2022","journal-title":"Cellular Immunology"},{"key":"10.1016\/j.biopha.2023.115734_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.121048","article-title":"Investigating the possible mechanisms of pirfenidone to be targeted as a promising anti-inflammatory, anti-fibrotic, anti-oxidant, anti-apoptotic, anti-tumor, and\/or anti-SARS-CoV-2","volume":"309","author":"Antar","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2023.115734_bib55","doi-asserted-by":"crossref","unstructured":"J. Yu, M. Li, D. Zhan, C. Shi, L. Fang, C. Ban, W. Zheng, V. Veeraraghavan, S. Mohan, X.J.P.M. Tang, Inhibitory effects of triterpenoid betulin on inflammatory mediators inducible nitric oxide synthase, cyclooxygenase-2, tumor necrosis factor-alpha, interleukin-6, and proliferating cell nuclear antigen in 1, 2-dimethylhydrazine-induced rat colon carcinogenesis, 16(72) (2020). https:\/\/go.gale.com\/ps\/i.do?p=AONE&u=googlescholar&id=GALE|A652828218&v=2.1&it=r&sid=googleScholar&asid=0a1aef72.","DOI":"10.4103\/pm.pm_516_19"},{"issue":"8","key":"10.1016\/j.biopha.2023.115734_bib56","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41574-021-00510-4","article-title":"Therapeutic opportunities for pancreatic \u03b2-cell ER stress in diabetes mellitus","volume":"17","author":"Yong","year":"2021","journal-title":"Nature Reviews Endocrinology"},{"issue":"2","key":"10.1016\/j.biopha.2023.115734_bib57","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s40257-022-00751-7","article-title":"Review of an anti-CD20 monoclonal antibody for the treatment of autoimmune diseases of the skin","volume":"24","author":"Ly","year":"2023","journal-title":"American journal of clinical dermatology"},{"key":"10.1016\/j.biopha.2023.115734_bib58","author":"Schmidt","year":"2003","journal-title":"Diabesity: Inflamm. Metab. Cond."},{"issue":"1","key":"10.1016\/j.biopha.2023.115734_bib59","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1196\/annals.1372.039","article-title":"Inflammatory process in type 2 diabetes: The role of cytokines","volume":"1084","author":"Alexandraki","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"12","key":"10.1016\/j.biopha.2023.115734_bib60","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1080\/13543784.2022.2022119","article-title":"Investigational therapies targeting CD3 for prevention and treatment of type 1 diabetes","volume":"30","author":"Mignogna","year":"2021","journal-title":"Expert Opinion on Investigational Drugs"},{"issue":"1","key":"10.1016\/j.biopha.2023.115734_bib61","first-page":"50","article-title":"The role of inflammation in diabetes: current concepts and future perspectives","volume":"14","author":"Tsalamandris","year":"2019"},{"issue":"22","key":"10.1016\/j.biopha.2023.115734_bib62","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1056\/NEJMoa0904452","article-title":"Rituximab, B-lymphocyte depletion, and preservation of beta-cell function","volume":"361","author":"Pescovitz","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2023.115734_bib63","doi-asserted-by":"crossref","unstructured":"S.S. Park, R. Rodriguez Ortega, C.W. Agudelo, J. Perez Perez, B. Perez Gandara, I. Garcia-Arcos, C. McCarthy, P.J.M. Geraghty, Therapeutic potential of alpha-1 antitrypsin in Type 1 and Type 2 diabetes mellitus, 57(4), 2021: 397. https:\/\/doi.org\/10.3390\/medicina57040397.","DOI":"10.3390\/medicina57040397"},{"issue":"2","key":"10.1016\/j.biopha.2023.115734_bib64","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2337\/dc13-0626","article-title":"B-lymphocyte depletion with rituximab and \u03b2-cell function: two-year results","volume":"37","author":"Pescovitz","year":"2014","journal-title":"Diabetes care"},{"issue":"6","key":"10.1016\/j.biopha.2023.115734_bib65","first-page":"1090","volume":"11","author":"Berretta","year":"2022","journal-title":"Mult. Eff. Vitam. D. Chronic Dis.: Reduct. Lipid Peroxidation Update Evid. Clin. Stud."},{"issue":"22","key":"10.1016\/j.biopha.2023.115734_bib66","first-page":"6908","article-title":"Effect of Vitamin D supplementation in patients with liver cirrhosis having spontaneous bacterial peritonitis: a randomized controlled study","volume":"25","author":"Mohamed","year":"2021","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2023.115734_bib67","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.2337\/dc09-0054","article-title":"Etanercept treatment in children with new-onset type 1 diabetes: pilot randomized, placebo-controlled, double-blind study","volume":"32","author":"Mastrandrea","year":"2009","journal-title":"Diabetes care"},{"issue":"8","key":"10.1016\/j.biopha.2023.115734_bib68","doi-asserted-by":"crossref","first-page":"E1418","DOI":"10.1210\/jc.2013-3864","article-title":"\u03b11-Antitrypsin therapy downregulates toll-like receptor-induced IL-1\u03b2 responses in monocytes and myeloid dendritic cells and may improve islet function in recently diagnosed patients with type 1 diabetes","volume":"99","author":"Gottlieb","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.biopha.2023.115734_bib69","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.clnu.2013.01.012","article-title":"A randomized placebo-controlled trial of alphacalcidol on the preservation of beta cell function in children with recent onset type 1 diabetes","volume":"32","author":"Ataie-Jafari","year":"2013","journal-title":"Clin. Nutr."},{"issue":"2","key":"10.1016\/j.biopha.2023.115734_bib70","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1464-5491.2007.2065_1.x","article-title":"The effects of calcitriol and nicotinamide on residual pancreatic beta-cell funtion in patients with recent-onset Type 1 diabetes (IMDIAB XI)","volume":"24","author":"Boucher","year":"2007","journal-title":"Diabet. Med.: a J. Br. Diabet. Assoc."},{"issue":"402","key":"10.1016\/j.biopha.2023.115734_bib71","doi-asserted-by":"crossref","first-page":"eaaf7779","DOI":"10.1126\/scitranslmed.aaf7779","article-title":"Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes","volume":"9","author":"Alhadj Ali","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"191","key":"10.1016\/j.biopha.2023.115734_bib72","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006103","article-title":"Plasmid-encoded proinsulin preserves C-peptide while specifically reducing proinsulin-specific CD8+ T cells in type 1 diabetes","volume":"5","author":"Roep","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"9","key":"10.1016\/j.biopha.2023.115734_bib73","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.2337\/dc18-0494","article-title":"Low-dose anti-thymocyte globulin (ATG) preserves \u03b2-cell function and improves HbA1c in new-onset type 1 diabetes","volume":"41","author":"Haller","year":"2018","journal-title":"Diabetes care"},{"issue":"1","key":"10.1016\/j.biopha.2023.115734_bib74","doi-asserted-by":"crossref","first-page":"50","DOI":"10.15420\/ecr.2018.33.1","article-title":"The role of inflammation in diabetes: current concepts and future perspectives","volume":"14","author":"Tsalamandris","year":"2019","journal-title":"Eur. Cardiol. Rev."},{"key":"10.1016\/j.biopha.2023.115734_bib75","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1590\/S1516-31802001000300008","article-title":"Chronic activation of the innate immune system may underlie the metabolic syndrome","volume":"119","author":"Duncan","year":"2001","journal-title":"Sao Paulo Med. J."},{"issue":"3","key":"10.1016\/j.biopha.2023.115734_bib76","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2337\/diabetes.53.3.693","article-title":"Inflammatory markers and risk of developing type 2 diabetes in women","volume":"53","author":"Hu","year":"2004","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.biopha.2023.115734_bib77","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.hepres.2005.09.032","article-title":"Role of suppressors of cytokine signaling SOCS-1 and SOCS-3 in hepatic steatosis and the metabolic syndrome","volume":"33","author":"Ueki","year":"2005","journal-title":"Hepatol. Res."},{"issue":"4","key":"10.1016\/j.biopha.2023.115734_bib78","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s11892-003-0020-2","article-title":"Adipokines, inflammation, and the endothelium in diabetes","volume":"3","author":"Aldhahi","year":"2003","journal-title":"Curr. Diabetes Rep."},{"issue":"11","key":"10.1016\/j.biopha.2023.115734_bib79","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/j.jacc.2005.06.082","article-title":"Inflammatory markers and the metabolic syndrome: insights from therapeutic interventions","volume":"46","author":"Koh","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"issue":"8","key":"10.1016\/j.biopha.2023.115734_bib80","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/oby.2005.159","article-title":"Diet induction of monocyte chemoattractant protein\u20101 and its impact on obesity","volume":"13","author":"Chen","year":"2005","journal-title":"Obes. Res."},{"issue":"6","key":"10.1016\/j.biopha.2023.115734_bib81","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1172\/JCI200215318","article-title":"Glucose-induced \u03b2 cell production of IL-1\u03b2 contributes to glucotoxicity in human pancreatic islets","volume":"110","author":"Maedler","year":"2002","journal-title":"J. Clin. Investig."},{"issue":"45","key":"10.1016\/j.biopha.2023.115734_bib82","doi-asserted-by":"crossref","first-page":"45021","DOI":"10.1074\/jbc.M307878200","article-title":"Adiponectin stimulates production of nitric oxide in vascular endothelial cells","volume":"278","author":"Chen","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2023.115734_bib83","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s00109-002-0378-7","article-title":"Adiponectin: a link between excess adiposity and associated comorbidities?","volume":"80","author":"Ukkola","year":"2002","journal-title":"J. Mol. Med."},{"issue":"4","key":"10.1016\/j.biopha.2023.115734_bib84","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1128\/MCB.25.4.1569-1575.2005","article-title":"Activation of SOCS-3 by resistin","volume":"25","author":"Steppan","year":"2005","journal-title":"Mol. Cell. Biol."},{"issue":"6818","key":"10.1016\/j.biopha.2023.115734_bib85","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35053000","article-title":"The hormone resistin links obesity to diabetes","volume":"409","author":"Steppan","year":"2001","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.biopha.2023.115734_bib86","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1161\/hh2401.101272","article-title":"CD40 signaling and plaque instability","volume":"89","author":"Sch\u00f6nbeck","year":"2001","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2023.115734_bib87","article-title":"Anti-inflammatory phytochemicals for the treatment of diabetes and its complications: Lessons learned and future promise","volume":"133","author":"Kong","year":"2021","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.biopha.2023.115734_bib88","article-title":"A novel inflammatory signaling pathway in patients with slow coronary flow: NF-\u03baB\/IL-1\u03b2\/nitric oxide","volume":"143","author":"Roshanravan","year":"2021"},{"issue":"2","key":"10.1016\/j.biopha.2023.115734_bib89","first-page":"183","article-title":"Insulin resistance and oxidative marker in women with PCOS","volume":"126","author":"Bannigida","year":"2020","journal-title":"biochemistry"},{"issue":"7","key":"10.1016\/j.biopha.2023.115734_bib90","first-page":"577","article-title":"Anti-Inflammatory Properties of Metformin During Cultivation of Primary Rat Astrocytes in a Medium with High Glucose Concentration","volume":"87","author":"Gorbatenko","year":"2022"},{"issue":"6","key":"10.1016\/j.biopha.2023.115734_bib91","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jacbts.2020.02.004","article-title":"Mechanisms of cardiovascular benefits of sodium glucose co-transporter 2 (SGLT2) inhibitors: a state-of-the-art review","volume":"5","author":"Lopaschuk","year":"2020","journal-title":"Basic to Translational Science"},{"issue":"12","key":"10.1016\/j.biopha.2023.115734_bib92","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/dom.12357","article-title":"The interleukin\u20101 receptor antagonist anakinra improves first\u2010phase insulin secretion and insulinogenic index in subjects with impaired glucose tolerance","volume":"16","author":"van Poppel","year":"2014","journal-title":"Diabetes, Obes. Metab."},{"issue":"2","key":"10.1016\/j.biopha.2023.115734_bib93","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.clim.2015.06.003","article-title":"One week treatment with the IL-1 receptor antagonist anakinra leads to a sustained improvement in insulin sensitivity in insulin resistant patients with type 1 diabetes mellitus","volume":"160","author":"van Asseldonk","year":"2015","journal-title":"Clin. Immunol."},{"issue":"8","key":"10.1016\/j.biopha.2023.115734_bib94","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.2337\/dc11-2219","article-title":"Effects of gevokizumab on glycemia and inflammatory markers in type 2 diabetes","volume":"35","author":"Cavelti-Weder","year":"2012","journal-title":"Diabetes care"},{"issue":"6","key":"10.1016\/j.biopha.2023.115734_bib95","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.diabet.2013.07.003","article-title":"Impact of interleukin-1\u03b2 antibody (canakinumab) on glycaemic indicators in patients with type 2 diabetes mellitus: results of secondary endpoints from a randomized, placebo-controlled trial","volume":"39","author":"Hensen","year":"2013","journal-title":"Diabetes Metab."},{"issue":"21","key":"10.1016\/j.biopha.2023.115734_bib96","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1016\/j.jacc.2018.03.002","article-title":"Anti-inflammatory therapy with canakinumab for the prevention and management of diabetes","volume":"71","author":"Everett","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.biopha.2023.115734_bib97","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00592-011-0329-2","article-title":"Salsalate improves glycemic control in patients with newly diagnosed type 2 diabetes","volume":"50","author":"Faghihimani","year":"2013","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.biopha.2023.115734_bib98","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1007\/s00125-012-2819-3","article-title":"A randomised trial of salsalate for insulin resistance and cardiovascular risk factors in persons with abnormal glucose tolerance","volume":"56","author":"Goldfine","year":"2013","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.biopha.2023.115734_bib99","doi-asserted-by":"crossref","first-page":"E146","DOI":"10.1210\/jc.2010-1170","article-title":"TNF-\u03b1 antagonism with etanercept decreases glucose and increases the proportion of high molecular weight adiponectin in obese subjects with features of the metabolic syndrome","volume":"96","author":"Stanley","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.biopha.2023.115734_bib100","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1136\/ard.2004.026534","article-title":"Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis","volume":"64","author":"Kiortsis","year":"2005","journal-title":"Ann. Rheum. Dis."},{"issue":"7","key":"10.1016\/j.biopha.2023.115734_bib101","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2337\/dc11-0357","article-title":"Effect of diacerein on insulin secretion and metabolic control in drug-naive patients with type 2 diabetes: a randomized clinical trial","volume":"34","author":"Ramos-Zavala","year":"2011","journal-title":"Diabetes care"},{"issue":"8","key":"10.1016\/j.biopha.2023.115734_bib102","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJMoa1809798","article-title":"Low-dose methotrexate for the prevention of atherosclerotic events","volume":"380","author":"Ridker","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.biopha.2023.115734_bib103","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1002\/art.38652","article-title":"Effect of methotrexate use and erythrocyte methotrexate polyglutamate on glycosylated hemoglobin in rheumatoid arthritis","volume":"66","author":"De Rotte","year":"2014","journal-title":"Arthritis Rheumatol."},{"issue":"7","key":"10.1016\/j.biopha.2023.115734_bib104","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1002\/art.22663","article-title":"Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: A randomized, double\u2010blind, placebo\u2010controlled trial in asymptomatic antiphospholipid antibody\u2013positive individuals","volume":"56","author":"Erkan","year":"2007","journal-title":"Arthritis Rheum.: Off. J. Am. Coll. Rheumatol."},{"key":"10.1016\/j.biopha.2023.115734_bib105","article-title":"Adipose tissue and insulin resistance in obese","volume":"137","author":"Ahmed","year":"2021","journal-title":"Pharmacotherapy"},{"issue":"7785","key":"10.1016\/j.biopha.2023.115734_bib106","first-page":"51","article-title":"The integrative biology of type 2 diabetes","volume":"576","author":"Roden","year":"2019"},{"key":"10.1016\/j.biopha.2023.115734_bib107","article-title":"Adipose tissue distribution, inflammation and its metabolic consequences, including diabetes and cardiovascular disease","volume":"7","author":"Chait","year":"2020"},{"issue":"4","key":"10.1016\/j.biopha.2023.115734_bib108","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/08830185.2019.1638921","volume":"38","author":"Singh","year":"2019","journal-title":"International reviews of immunology"},{"issue":"18","key":"10.1016\/j.biopha.2023.115734_bib109","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202100275","article-title":"Emerging targets in type 2 diabetes and diabetic complications","volume":"8","author":"Demir","year":"2021","journal-title":"Adv. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2023.115734_bib110","article-title":"Increased plasmablasts enhance T cell-mediated beta cell destruction and promote the development of type 1 diabetes","volume":"28","author":"Ling","year":"2022"},{"issue":"4","key":"10.1016\/j.biopha.2023.115734_bib111","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.3390\/ijms22041765","article-title":"Crosstalk between macrophages and pancreatic \u03b2-cells in islet development, homeostasis and disease","volume":"22","author":"Cosentino","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"3","key":"10.1016\/j.biopha.2023.115734_bib112","doi-asserted-by":"crossref","first-page":"130","DOI":"10.4239\/wjd.v14.i3.130","article-title":"Pancreatic \u03b2-cell dysfunction in type 2 diabetes: Implications of inflammation and oxidative stress","volume":"14","author":"Dludla","year":"2023","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.biopha.2023.115734_bib113","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.lfs.2016.02.002","article-title":"Oxidative stress and metabolic disorders: Pathogenesis and therapeutic strategies","volume":"148","author":"Rani","year":"2016","journal-title":"Life Sci."},{"issue":"9","key":"10.1016\/j.biopha.2023.115734_bib114","first-page":"2224","article-title":"Anti-inflammatory strategies targeting metaflammation in type 2 diabetes","volume":"25","author":"Kury\u0142owicz","year":"2020"},{"issue":"3","key":"10.1016\/j.biopha.2023.115734_bib115","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2337\/diacare.27.3.813","article-title":"Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes","volume":"27","author":"Pickup","year":"2004","journal-title":"Diabetes care"},{"key":"10.1016\/j.biopha.2023.115734_bib116","article-title":"Adipose extracellular vesicles in intercellular and inter-organ crosstalk in metabolic health and diseases","volume":"12","author":"Huang","year":"2021"},{"key":"10.1016\/j.biopha.2023.115734_bib117","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00204-015-1579-5","article-title":"Redox-and non-redox-metal-induced formation of free radicals and their role in human disease","volume":"90","author":"Valko","year":"2016","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.biopha.2023.115734_bib118","article-title":"Molecular mechanisms of oxidative stress in stroke and cancer","volume":"5","author":"Chavda","year":"2022"},{"key":"10.1016\/j.biopha.2023.115734_bib119","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.freeradbiomed.2021.02.015","article-title":"Reactive Oxygen Species in intestinal stem cell metabolism, fate and function","volume":"166","author":"Morris","year":"2021","journal-title":"Free Radical Biology and Medicine"},{"key":"10.1016\/j.biopha.2023.115734_bib120","doi-asserted-by":"crossref","unstructured":"G. Martemucci, C. Costagliola, M. Mariano, L. D\u2019andrea, P. Napolitano, A.G.J.O. D\u2019Alessandro, Free radical properties, source and targets, antioxidant consumption and health, 2(2), 2022: 48\u201378. https:\/\/doi.org\/10.3390\/oxygen2020006.","DOI":"10.3390\/oxygen2020006"},{"issue":"6","key":"10.1016\/j.biopha.2023.115734_bib121","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.1007\/s11033-022-07341-0","article-title":"Oxidative stress and alterations in the expression of genes related to inflammation, DNA damage, and metal exposure in lung cells exposed to a hydroethanolic coal dust extract","volume":"49","author":"Tirado-Ballestas","year":"2022","journal-title":"Molecular Biology Reports"},{"key":"10.1016\/j.biopha.2023.115734_bib122","volume":"37","author":"Kang","year":"2020","journal-title":"Oxid. Stress Diabet. Retin.: Mol. Mech., Pathog. role Ther. Implic."},{"key":"10.1016\/j.biopha.2023.115734_bib123","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2020.02.025","article-title":"Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease","volume":"152","author":"Chen","year":"2020","journal-title":"Free Radical Biology and Medicine"},{"key":"10.1016\/j.biopha.2023.115734_bib124","doi-asserted-by":"crossref","unstructured":"M.E.J.M. Cerf, Beta cell physiological dynamics and dysfunctional transitions in response to islet inflammation in obesity and diabetes, 10(11), 2020: 452. https:\/\/doi.org\/10.3390\/metabo10110452.","DOI":"10.3390\/metabo10110452"},{"key":"10.1016\/j.biopha.2023.115734_bib125","doi-asserted-by":"crossref","unstructured":"I.A. Anastasiou, I. Eleftheriadou, A. Tentolouris, C. Koliaki, O.A. Kosta, N.J.Cmc Tentolouris, The effect of oxidative stress and antioxidant therapies on pancreatic \u03b2-cell dysfunction: results from in vitro and in vivo studies, 28(7), 2021: 1328\u20131346. https:\/\/doi.org\/10.2174\/0929867327666200526135642.","DOI":"10.2174\/0929867327666200526135642"},{"key":"10.1016\/j.biopha.2023.115734_bib126","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.freeradbiomed.2022.03.019","article-title":"Oxidative stress in the pathophysiology of type 2 diabetes and related complications: Current therapeutics strategies and future perspectives","volume":"184","author":"Bhatti","year":"2022","journal-title":"Free Radical Biology and Medicine"},{"key":"10.1016\/j.biopha.2023.115734_bib127","volume":"2020","author":"Yaribeygi","year":"2020","journal-title":"Mol. Mech. Link. Oxid. Stress Diabetes Mellit."},{"key":"10.1016\/j.biopha.2023.115734_bib128","doi-asserted-by":"crossref","unstructured":"M. Soleimani-Dodran, R. Alipanah-Moghadam, F. Jeddi, M. Babaei, R. Salimnejad, E.J.N. Bahreini, Metabolism, Effect of hydroalcoholic seed extract of Nigella sativa on hepatic and pancreatic factors of Nrf2 and FGF21 in the regulation of insulin transcription factors of MafA and PDX-1 in streptozotocin-treated diabetic rats, 19(1), 2022: 1\u201312. https:\/\/doi.org\/10.1186\/s12986\u2013022-00699\u20139.","DOI":"10.1186\/s12986-022-00699-9"},{"issue":"6","key":"10.1016\/j.biopha.2023.115734_bib129","first-page":"576","volume":"8","author":"Li","year":"2019","journal-title":"Roles toll- Recept. nitroxidative Stress Mamm."},{"key":"10.1016\/j.biopha.2023.115734_bib130","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.coph.2021.11.010","article-title":"The molecular link between oxidative stress, insulin resistance, and type 2 diabetes: A target for new therapies against cardiovascular diseases","volume":"62","author":"Andreadi","year":"2022","journal-title":"Current opinion in pharmacology"},{"key":"10.1016\/j.biopha.2023.115734_bib131","doi-asserted-by":"crossref","unstructured":"H. Cabrera-Cruz, L. Or\u00f3stica, F. Plaza-Parrochia, I. Torres-Pinto, C. Romero, M.J.Ajop-e Vega, metabolism, The insulin-sensitizing mechanism of myo-inositol is associated with AMPK activation and GLUT-4 expression in human endometrial cells exposed to a PCOS environment, 318(2), 2020: E237-E248. https:\/\/doi.org\/10.1152\/ajpendo.00162.2019.","DOI":"10.1152\/ajpendo.00162.2019"},{"key":"10.1016\/j.biopha.2023.115734_bib132","doi-asserted-by":"crossref","unstructured":"H.H. Shen, S.J. Peterson, L. Bellner, A. Choudhary, L. Levy, L. Gancz, A. Sasson, J. Trainer, R. Rezzani, A.J.A. Resnick, Cold-pressed Nigella sativa oil standardized to 3% thymoquinone potentiates omega-3 protection against obesity-induced oxidative stress, inflammation, and markers of insulin resistance accompanied with conversion of white to beige fat in mice, 9(6), 2020: 489. https:\/\/doi.org\/10.3390\/antiox9060489.","DOI":"10.3390\/antiox9060489"},{"key":"10.1016\/j.biopha.2023.115734_bib133","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.freeradbiomed.2015.06.021","article-title":"Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease","volume":"88","author":"Tebay","year":"2015","journal-title":"Free Radical Biology and Medicine"},{"issue":"6","key":"10.1016\/j.biopha.2023.115734_bib134","first-page":"711","volume":"26","author":"Osellame","year":"2012","journal-title":"Cell. Mol. Mech. mitochondrial Funct."},{"issue":"1","key":"10.1016\/j.biopha.2023.115734_bib135","first-page":"73","volume":"39","author":"Islam","year":"2017","journal-title":"Oxid. Stress mitochondrial Dysfunct. -linked Neurodegener. Disord."},{"issue":"9","key":"10.1016\/j.biopha.2023.115734_bib136","first-page":"435","volume":"23","author":"Kusminski","year":"2012","journal-title":"Mitochondrial Dysfunct. White Adipose Tissue"},{"issue":"2","key":"10.1016\/j.biopha.2023.115734_bib137","first-page":"167","volume":"212","author":"Rolo","year":"2006","journal-title":"Diabetes mitochondrial Funct.: role hyperglycemia Oxid. Stress"},{"issue":"4","key":"10.1016\/j.biopha.2023.115734_bib138","first-page":"656","volume":"15","author":"Davies","year":"2019","journal-title":"Alter. gut Micro Bariatr. Surg. its Assoc. Metab. Benefit.: A Syst. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2023.115734_bib139","first-page":"1897212","volume":"13","author":"Nogal","year":"2021","journal-title":"role Short. -chain Fat. Acids Inter. gut Micro Diet. cardio-Metab. Health"},{"issue":"1","key":"10.1016\/j.biopha.2023.115734_bib140","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jid.2020.04.031","article-title":"Induction of regulatory T cells and correction of cytokine disbalance by short-chain fatty acids: implications for psoriasis therapy","volume":"141","author":"Schwarz","year":"2021","journal-title":"Journal of Investigative Dermatology"},{"key":"10.1016\/j.biopha.2023.115734_bib141","volume":"117","author":"Yang","year":"2021","journal-title":"Role gut Micro Type 2 Diabetes Relat. Dis."},{"issue":"1","key":"10.1016\/j.biopha.2023.115734_bib142","first-page":"4","volume":"18","author":"Wang","year":"2021","journal-title":"Gut Micro, liver Immunol., liver Dis."},{"issue":"3","key":"10.1016\/j.biopha.2023.115734_bib143","first-page":"280","volume":"15","author":"Garcia-Compean","year":"2009","journal-title":"Liver cirrhosis Diabetes.: risk Factors, Pathophysiol., Clin. Implic. Manag."},{"issue":"5","key":"10.1016\/j.biopha.2023.115734_bib144","first-page":"987","volume":"42","author":"Bugianesi","year":"2005","journal-title":"Insul. Resist.: a Metab. Pathw. Chronic liver Dis."},{"issue":"4","key":"10.1016\/j.biopha.2023.115734_bib145","first-page":"166","volume":"19","author":"Elsahar","year":"2018","journal-title":"Manag. Diabetes liver Dis. Assoc."},{"issue":"2","key":"10.1016\/j.biopha.2023.115734_bib146","first-page":"158","volume":"25","author":"Helenius\u2010Hietala","year":"2012","journal-title":"Eff. Aetiol. Sev. liver Dis. Oral. Health Dent. Treat. Transplant."},{"issue":"9","key":"10.1016\/j.biopha.2023.115734_bib147","first-page":"289","volume":"60","author":"Mehta","year":"2002","journal-title":"Nonalcoholic Fat. liver Dis.: Pathog. role Antioxid."},{"issue":"4","key":"10.1016\/j.biopha.2023.115734_bib148","first-page":"637","volume":"28","author":"Dietrich","year":"2014","journal-title":"Non-Alcohol. Fat. liver Dis., Obes. Metab. Syndr."},{"key":"10.1016\/j.biopha.2023.115734_bib149","first-page":"64","volume":"28","author":"Hashimoto","year":"2013","journal-title":"Charact. Diagn. NAFLD\/NASH"},{"issue":"2","key":"10.1016\/j.biopha.2023.115734_bib150","first-page":"373","volume":"35","author":"Chitturi","year":"2002","journal-title":"NASH Insul. Resist.: Insul. hypersecretion Specif. Assoc. Insul. Resist. Syndr."},{"issue":"3","key":"10.1016\/j.biopha.2023.115734_bib151","first-page":"347","volume":"92","author":"Trayhurn","year":"2004","journal-title":"Adipokines: Inflamm. pleiotropic role White Adipose Tissue"},{"key":"10.1016\/j.biopha.2023.115734_bib152","doi-asserted-by":"crossref","unstructured":"K. Qureshi, G.A.J.WjogW. Abrams, Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease, 13(26), 2007: 3540. https:\/\/doi.org\/10.3748\/wjg.v13.i26.3540.","DOI":"10.3748\/wjg.v13.i26.3540"},{"issue":"4","key":"10.1016\/j.biopha.2023.115734_bib153","first-page":"363","article-title":"The role of cytokines in non-alcoholic steatohepatitis","volume":"15","author":"Copaci","year":"2006","journal-title":"A Syst. Rev."},{"issue":"9","key":"10.1016\/j.biopha.2023.115734_bib154","first-page":"1194","volume":"44","author":"Thomsen","year":"2007","journal-title":"Diabetes Mellit. pyogenic liver abscess: risk Progn."},{"issue":"1","key":"10.1016\/j.biopha.2023.115734_bib155","first-page":"1","volume":"6","author":"Kim","year":"2015","journal-title":"Chronic Alcohol Consum. potentiates Dev. Diabetes Pancreat. \u03b2-Cell Dysfunct."},{"key":"10.1016\/j.biopha.2023.115734_bib156","volume":"2016","author":"Patschan","year":"2016","journal-title":"Acute Kidney Inj. Diabetes Mellit."},{"issue":"1","key":"10.1016\/j.biopha.2023.115734_bib157","first-page":"1","article-title":"Diabetic kidney disease","volume":"1","author":"Thomas","year":"2015","journal-title":"Nature reviews Disease primers"},{"key":"10.1016\/j.biopha.2023.115734_bib158","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.120185","article-title":"Pirfenidone and vitamin D mitigate renal fibrosis induced by doxorubicin in mice with Ehrlich solid tumor","volume":"288","author":"Hazem","year":"2022","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.biopha.2023.115734_bib159","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/PAP.0000000000000257","article-title":"Diabetic kidney disease: Past and present","volume":"27","author":"Akhtar","year":"2020","journal-title":"Advances in anatomic pathology"},{"issue":"2","key":"10.1016\/j.biopha.2023.115734_bib160","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2337\/dbi20-0030","article-title":"Epigenetic mechanisms in diabetic vascular complications and metabolic memory: The 2020 Edwin Bierman Award Lecture","volume":"70","author":"Natarajan","year":"2021","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.biopha.2023.115734_bib161","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.cmet.2017.01.004","article-title":"Reducing VEGF-B signaling ameliorates renal lipotoxicity and protects against diabetic kidney disease","volume":"25","author":"Falkevall","year":"2017","journal-title":"Cell Metab."},{"issue":"4","key":"10.1016\/j.biopha.2023.115734_bib162","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jacc.2019.11.031","article-title":"Mechanisms of cardiorenal effects of sodium-glucose cotransporter 2 inhibitors: JACC state-of-the-art review","volume":"75","author":"Zelniker","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"11","key":"10.1016\/j.biopha.2023.115734_bib163","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1093\/ndt\/gfx377","article-title":"JAK1\/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial","volume":"33","author":"Tuttle","year":"2018","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.biopha.2023.115734_bib164","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.00187","article-title":"Transforming growth factor-beta1 in diabetic kidney disease","volume":"8","author":"Zhao","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115734_bib165","first-page":"835","article-title":"ROS induces epithelial\u2011mesenchymal transition via the TGF\u2011\u03b21\/PI3K\/Akt\/mTOR pathway in diabetic nephropathy","volume":"17","author":"Lu","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.biopha.2023.115734_bib166","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3389\/fphys.2015.00082","article-title":"TGF-\u00df\/Smad signaling in renal fibrosis","volume":"6","author":"Meng","year":"2015","journal-title":"Front Physiol."},{"issue":"3","key":"10.1016\/j.biopha.2023.115734_bib167","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.cmet.2020.06.020","article-title":"SGLT2 inhibition mediates protection from diabetic kidney disease by promoting ketone body-induced mTORC1 inhibition","volume":"32","author":"Tomita","year":"2020","journal-title":"Cell Metab."},{"issue":"24","key":"10.1016\/j.biopha.2023.115734_bib168","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.biopha.2023.115734_bib169","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S2213-8587(19)30256-6","article-title":"SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"7","author":"Neuen","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"24","key":"10.1016\/j.biopha.2023.115734_bib170","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1161\/CIRCULATIONAHA.116.022194","article-title":"Clinical update: cardiovascular disease in diabetes mellitus: atherosclerotic cardiovascular disease and heart failure in type 2 diabetes mellitus\u2013mechanisms, management, and clinical considerations","volume":"133","author":"Low Wang","year":"2016","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.biopha.2023.115734_bib171","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-018-0728-6","article-title":"Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007\u20132017","volume":"17","author":"Einarson","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"issue":"5","key":"10.1016\/j.biopha.2023.115734_bib172","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1161\/ATVBAHA.115.306770","article-title":"Regulation of vascular smooth muscle cell dysfunction under diabetic conditions by miR-504","volume":"36","author":"Reddy","year":"2016","journal-title":"Arterioscler., Thromb., Vasc. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115734_bib173","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-18712-1","article-title":"Targeting QKI-7 in vivo restores endothelial cell function in diabetes","volume":"11","author":"Yang","year":"2020","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.biopha.2023.115734_bib174","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.86574","article-title":"Insulin decreases atherosclerosis by inducing endothelin receptor B expression","volume":"1","author":"Park","year":"2016","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.biopha.2023.115734_bib175","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1002\/ehf2.12789","article-title":"Diabetes mellitus exacerbates post\u2010myocardial infarction heart failure by reducing sarcolipin promoter methylation","volume":"7","author":"Liu","year":"2020","journal-title":"ESC Heart Fail."},{"issue":"7","key":"10.1016\/j.biopha.2023.115734_bib176","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/CIRCULATIONAHA.117.031942","article-title":"O-GlcNAcylation of histone deacetylase 4 protects the diabetic heart from failure","volume":"140","author":"Kronlage","year":"2019","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.biopha.2023.115734_bib177","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.cell.2020.08.031","article-title":"A network of macrophages supports mitochondrial homeostasis in the heart","volume":"183","author":"Nicol\u00e1s-\u00c1vila","year":"2020","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.biopha.2023.115734_bib178","first-page":"442","volume":"16","author":"Berbudi","year":"2020","journal-title":"Type 2 Diabetes its Impact Immune Syst."},{"key":"10.1016\/j.biopha.2023.115734_bib179","article-title":"Metabolomics driven analysis of Nigella sativa seeds identifies the impact of roasting on the chemical composition and immunomodulatory activity","author":"Salem","year":"2022","journal-title":"Food Chem."},{"key":"10.1016\/j.biopha.2023.115734_bib180","doi-asserted-by":"crossref","first-page":"34S","DOI":"10.14219\/jada.archive.2003.0370","article-title":"The influence of diabetes on the periodontal tissues","volume":"134","author":"Ryan","year":"2003","journal-title":"The Journal of the American Dental Association"},{"key":"10.1016\/j.biopha.2023.115734_bib181","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120691","article-title":"A novel role of Nano selenium and sildenafil on streptozotocin-induced diabetic nephropathy in rats by modulation of inflammatory, oxidative, and apoptotic pathways","volume":"303","author":"El-Azab","year":"2022","journal-title":"Life Sci."},{"issue":"7","key":"10.1016\/j.biopha.2023.115734_bib182","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.tem.2009.03.010","article-title":"Methylglyoxal: possible link between hyperglycaemia and immune suppression?","volume":"20","author":"Price","year":"2009","journal-title":"Trends in Endocrinology & Metabolism"},{"key":"10.1016\/j.biopha.2023.115734_bib183","doi-asserted-by":"crossref","unstructured":"P. Meenakshi, S. Ramya, J. Lavanya, V. Vijayalakshmi, G.J.C. Sumanlatha, Effect of IFN-\u03b3, IL-12 and IL-10 cytokine production and mRNA expression in tuberculosis patients with diabetes mellitus and their household contacts, 81, 2016: 127\u2013136. https:\/\/doi.org\/10.1016\/j.cyto.2016.03.009.","DOI":"10.1016\/j.cyto.2016.03.009"},{"key":"10.1016\/j.biopha.2023.115734_bib184","series-title":"Seminars in nephrology","first-page":"290","article-title":"Macrophages and diabetic nephropathy","author":"Tesch","year":"2010"},{"key":"10.1016\/j.biopha.2023.115734_bib185","first-page":"427","volume":"61","author":"Frazao","year":"2013","journal-title":"Toll- receptors\u2019 Pathw. Disturb. are Assoc. Increase susceptibility Infect. Hum."},{"key":"10.1016\/j.biopha.2023.115734_bib186","doi-asserted-by":"crossref","unstructured":"N. Rojo\u2010Botello, A. Garc\u00eda\u2010Hern\u00e1ndez, L.J.Jopr Moreno\u2010Fierros, Expression of toll\u2010like receptors 2, 4 and 9 is increased in gingival tissue from patients with type 2 diabetes and chronic periodontitis, 47(1), 2012: 62\u201373. https:\/\/doi.org\/10.1111\/j.1600\u20130765.2011.01405.x.","DOI":"10.1111\/j.1600-0765.2011.01405.x"},{"issue":"10","key":"10.1016\/j.biopha.2023.115734_bib187","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.1073\/pnas.1814711116","article-title":"NOTCH1 signaling induces pathological vascular permeability in diabetic retinopathy","volume":"116","author":"Miloudi","year":"2019","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2023.115734_bib188","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1159\/000493151","article-title":"Evaluation of Notch3 deficiency in diabetes-induced pericyte loss in the retina","volume":"55","author":"Liu","year":"2018","journal-title":"J. Vasc. Res."},{"issue":"2","key":"10.1016\/j.biopha.2023.115734_bib189","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201810154","article-title":"Inhibition of Sema4D\/PlexinB1 signaling alleviates vascular dysfunction in diabetic retinopathy","volume":"12","author":"Wu","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.biopha.2023.115734_bib190","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/5140521","article-title":"Angiopoietins in diabetic retinopathy: current understanding and therapeutic potential","volume":"2019","author":"Whitehead","year":"2019","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.biopha.2023.115734_bib191","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.pharmthera.2016.11.008","article-title":"Pericytes, an overlooked player in vascular pathobiology","volume":"171","author":"Ferland-McCollough","year":"2017","journal-title":"Pharmacol. Ther."},{"issue":"15","key":"10.1016\/j.biopha.2023.115734_bib192","doi-asserted-by":"crossref","first-page":"7455","DOI":"10.1073\/pnas.1814874116","article-title":"Targeting pericyte\u2013endothelial cell crosstalk by circular RNA-cPWWP2A inhibition aggravates diabetes-induced microvascular dysfunction","volume":"116","author":"Liu","year":"2019","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2023.115734_bib193","doi-asserted-by":"crossref","first-page":"3833","DOI":"10.1172\/JCI123353","article-title":"Circular RNA-ZNF532 regulates diabetes-induced retinal pericyte degeneration and vascular dysfunction","volume":"130","author":"Jiang","year":"2020","journal-title":"J. Clin. Investig."},{"issue":"9","key":"10.1016\/j.biopha.2023.115734_bib194","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jdiacomp.2019.05.016","article-title":"Diabetes induces IL-17A-Act1-FADD-dependent retinal endothelial cell death and capillary degeneration","volume":"33","author":"Lindstrom","year":"2019","journal-title":"J. Diabetes its Complicat."},{"issue":"4","key":"10.1016\/j.biopha.2023.115734_bib195","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3904\/kjim.2021.174","article-title":"The role of inflammation in diabetic kidney disease","volume":"36","author":"Jung","year":"2021","journal-title":"Korean J. Intern. Med."},{"key":"10.1016\/j.biopha.2023.115734_bib196","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00125-018-4755-3","article-title":"Prostaglandin E 2\/EP 2 receptor signalling pathway promotes diabetic retinopathy in a rat model of diabetes","volume":"62","author":"Wang","year":"2019","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.biopha.2023.115734_bib197","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/bph.14507","article-title":"Bioactive lipids and pathological retinal angiogenesis","volume":"176","author":"Elmasry","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2023.115734_bib198","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1007\/s00125-018-4701-4","article-title":"Anti-angiogenic effects of the DPP-4 inhibitor linagliptin via inhibition of VEGFR signalling in the mouse model of oxygen-induced retinopathy","volume":"61","author":"Kolibabka","year":"2018","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.biopha.2023.115734_bib199","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/ana.24524","article-title":"Magnetic resonance neurography detects diabetic neuropathy early and with proximal predominance","volume":"78","author":"Pham","year":"2015","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115734_bib200","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-64585-1","article-title":"Characterization of experimental diabetic neuropathy using multicontrast magnetic resonance neurography at ultra high field strength","volume":"10","author":"Schwarz","year":"2020","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.biopha.2023.115734_bib201","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/nm.2750","article-title":"Methylglyoxal modification of Nav1. 8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy","volume":"18","author":"Bierhaus","year":"2012","journal-title":"Nat. Med."},{"issue":"409","key":"10.1016\/j.biopha.2023.115734_bib202","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aam6072","article-title":"Hyperpolarization-activated cyclic nucleotide\u2013gated 2 (HCN2) ion channels drive pain in mouse models of diabetic neuropathy","volume":"9","author":"Tsantoulas","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"6","key":"10.1016\/j.biopha.2023.115734_bib203","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1172\/JCI92117","article-title":"Reducing CXCR4-mediated nociceptor hyperexcitability reverses painful diabetic neuropathy","volume":"128","author":"Jayaraj","year":"2018","journal-title":"J. Clin. Investig."},{"issue":"10","key":"10.1016\/j.biopha.2023.115734_bib204","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077986","article-title":"Methylglyoxal evokes pain by stimulating TRPA1","volume":"8","author":"Andersson","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.biopha.2023.115734_bib205","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3389\/fendo.2015.00088","article-title":"Identifying common genetic risk factors of diabetic neuropathies","volume":"6","author":"Witzel","year":"2015","journal-title":"Front. Endocrinol."},{"issue":"6","key":"10.1016\/j.biopha.2023.115734_bib206","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.neuron.2017.02.005","article-title":"New horizons in diabetic neuropathy: mechanisms, bioenergetics, and pain","volume":"93","author":"Feldman","year":"2017","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.biopha.2023.115734_bib207","article-title":"Interactions of Notch1 and TLR4 signaling pathways in DRG neurons of in vivo and in vitro models of diabetic neuropathy","volume":"7","author":"Chen","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2023.115734_bib208","doi-asserted-by":"crossref","first-page":"581","DOI":"10.3389\/fnins.2016.00581","article-title":"A role for insulin in diabetic neuropathy","volume":"10","author":"Grote","year":"2016","journal-title":"Front Neurosci."},{"issue":"3","key":"10.1016\/j.biopha.2023.115734_bib209","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nrneurol.2016.201","article-title":"Schwann cell interactions with axons and microvessels in diabetic neuropathy","volume":"13","author":"Gon\u00e7alves","year":"2017","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115734_bib210","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000488909","article-title":"Breathlessness and restrictive lung disease: an important diabetes-related feature in patients with type 2 diabetes","volume":"96","author":"Kopf","year":"2018","journal-title":"Respiration"},{"issue":"08","key":"10.1016\/j.biopha.2023.115734_bib211","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1055\/s-0043-106443","article-title":"Methylglyoxal and advanced glycation end products in patients with diabetes\u2013what we know so far and the missing links","volume":"127","author":"Groener","year":"2019","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"issue":"11","key":"10.1016\/j.biopha.2023.115734_bib212","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2019103477","article-title":"Compromised DNA repair is responsible for diabetes\u2010associated fibrosis","volume":"39","author":"Kumar","year":"2020","journal-title":"EMBO J."},{"issue":"18","key":"10.1016\/j.biopha.2023.115734_bib213","doi-asserted-by":"crossref","first-page":"10595","DOI":"10.1093\/nar\/gkx705","article-title":"Homeostatic nuclear RAGE\u2013ATM interaction is essential for efficient DNA repair","volume":"45","author":"Kumar","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.biopha.2023.115734_bib214","doi-asserted-by":"crossref","first-page":"229","DOI":"10.7762\/cnr.2018.7.4.229","article-title":"Diabetes and Alzheimer's disease: mechanisms and nutritional aspects","volume":"7","author":"Lee","year":"2018","journal-title":"Clin. Nutr. Res."},{"key":"10.1016\/j.biopha.2023.115734_bib215","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2147\/CIA.S74042","article-title":"Link between type 2 diabetes and Alzheimer's disease: from epidemiology to mechanism and treatment","author":"Li","year":"2015","journal-title":"Clin. Inter. Aging 10"},{"key":"10.1016\/j.biopha.2023.115734_bib216","doi-asserted-by":"crossref","DOI":"10.1016\/j.imu.2022.100960","article-title":"Bioinformatics and system biology approaches to identify molecular pathogenesis of polycystic ovarian syndrome, type 2 diabetes, obesity, and cardiovascular disease that are linked to the progression of female infertility","volume":"30","author":"Hossain","year":"2022","journal-title":"Inform. Med. Unlocked"},{"issue":"12","key":"10.1016\/j.biopha.2023.115734_bib217","doi-asserted-by":"crossref","first-page":"5808","DOI":"10.1210\/jc.2003-030254","article-title":"Occult Cushing\u2019s Syndrome in Type-2 Diabetes","volume":"88","author":"Catargi","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2023.115734_bib218","doi-asserted-by":"crossref","unstructured":"J. Wu, L. Tang, F. Zheng, X. Chen, L. Li, A review of the last decade: pancreatic cancer and type 2 diabetes, Archives of Physiology and Biochemistry 1\u20139. https:\/\/doi.org\/10.1080\/13813455.2023.2252204.","DOI":"10.1080\/13813455.2023.2252204"},{"issue":"11","key":"10.1016\/j.biopha.2023.115734_bib219","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1161\/CIRCRESAHA.119.316065","article-title":"Genetics Insights in the Relationship Between Type 2 Diabetes and Coronary Heart Disease","volume":"126","author":"Goodarzi","year":"2020","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.biopha.2023.115734_bib220","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.smim.2006.03.008","article-title":"Role of PTPN22 in type 1 diabetes and other autoimmune diseases","volume":"18","author":"Bottini","year":"2006","journal-title":"Semin. Immunol."},{"issue":"9","key":"10.1016\/j.biopha.2023.115734_bib221","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.autrev.2015.05.002","article-title":"Associated autoimmune diseases in children and adolescents with type 1 diabetes mellitus (T1DM)","volume":"14","author":"Kakleas","year":"2015","journal-title":"Autoimmun. Rev."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223015329?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223015329?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T21:08:18Z","timestamp":1779916098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223015329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":222,"alternative-id":["S0753332223015329"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115734","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetes mellitus: Classification, mediators, and complications; A gate to identify potential targets for the development of new effective treatments","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115734","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115734"}}